Preventing Genetic Identity Theft

A new report lays out the pitfalls of consumer genetics and suggested strategies for safeguarding DNA’s privacy.  

By | October 11, 2012

Wikimedia, Bolzer et al.With the price of whole genome sequencing plummeting from billions of dollars to the coveted $1,000 mark, policy makers and identify theft experts are scurrying to set up safety nets for genetic privacy protection. Today (October 11), the Presidential Commission for the Study of Bioethics released a report that finds current laws and guidance lacking, but provides recommendations to better protect individuals going forward.

“This is a proactive and a forward looking report,” commission chair Amy Gutmann said in a press conference yesterday (October 10). “In order to make full use of whole genome sequencing, which holds enormous promise for human health and medicine, we’re going to have to figure out how to protect people’s privacy and avoid the misuse of this very personal data.”

Though the commission found suitable protections when whole genome sequencing is carried out by clinicians—who are subject to the Health Insurance Portability and Accountability Act (HIPAA)—it revealed inadequate protection of genetic privacy in commercial and research arenas, which are so far only subject to Common Rule or Institutional Review Boards. For instance, only about half of US states protect individuals against surreptitious commercial sequencing.

“In many states in the U.S., someone could legally pick up your discarded coffee cup, send a sample of your saliva out for sequencing to see if you show a predisposition for certain diseases,” Gutmann explained. Though the costs have been a barrier in the past to such activities—the first human genome sequencing cost around $2.5 billion—experts predict it will soon drop below $1,000, which may lead to a flood of commercial sequencing.

The commission’s recommendations to improve security include: having state and federal governments establish basic protections, such as outlawing genome sequencing done without consent and improving data security for databases that store genetic information; new models for the consent process; and new methods for integrating whole genome sequence data into health records.

“Any of us should be protected, no matter what state of the union we live in,” Gutmann said, emphasizing that the recommendations weren’t intended to limit genome sequencing, but rather to provide protection and foster trust, and thus participation, in research involving the technique.

“Trust is the key to amassing the large number of genomic data sets needed to make powerful life-saving discoveries,” the commission wrote in a statement. 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham